RedHill Biopharma Ltd. (RDHL)
NASDAQ: RDHL · Real-Time Price · USD
1.305
-0.045 (-3.33%)
Oct 31, 2025, 1:05 PM EDT - Market open
RedHill Biopharma Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Cash & Equivalents | 2.87 | 1.88 | 5.57 | 19.97 | 29.47 | 29.3 | Upgrade |
Short-Term Investments | - | 2.74 | - | 0.02 | 8.53 | 0.02 | Upgrade |
Trading Asset Securities | - | - | - | - | - | 0.48 | Upgrade |
Cash & Short-Term Investments | 2.87 | 4.62 | 5.57 | 19.98 | 38 | 29.79 | Upgrade |
Cash Growth | -60.62% | -17.09% | -72.13% | -47.42% | 27.56% | -37.77% | Upgrade |
Accounts Receivable | 5.35 | 2.54 | 2.59 | 34.52 | 31.68 | 28.66 | Upgrade |
Other Receivables | - | 0.33 | 0.69 | 0.83 | 0.85 | 0.63 | Upgrade |
Receivables | 5.35 | 2.87 | 3.29 | 35.35 | 32.52 | 29.29 | Upgrade |
Inventory | 3.17 | 3.65 | 4.39 | 11.01 | 14.81 | 6.53 | Upgrade |
Prepaid Expenses | 1.01 | 0.69 | 0.8 | 2.52 | 3.18 | 2.34 | Upgrade |
Restricted Cash | 0.16 | - | 0.79 | 16 | - | - | Upgrade |
Other Current Assets | - | 0.08 | 1.31 | 1.03 | 0.63 | 2.54 | Upgrade |
Total Current Assets | 12.56 | 11.91 | 16.14 | 85.9 | 89.15 | 70.5 | Upgrade |
Property, Plant & Equipment | 0.29 | 0.44 | 1.18 | 7.19 | 4.22 | 5.7 | Upgrade |
Other Intangible Assets | 5.53 | 5.55 | 5.58 | 65.63 | 71.64 | 87.88 | Upgrade |
Other Long-Term Assets | - | 0.15 | 0.15 | 0.15 | 16.17 | 16.16 | Upgrade |
Total Assets | 18.38 | 18.04 | 23.05 | 158.87 | 181.19 | 180.24 | Upgrade |
Accounts Payable | 0.84 | 1.17 | 3.28 | 4.23 | 11.66 | 11.55 | Upgrade |
Accrued Expenses | 20.16 | 11.16 | 12.68 | 64.59 | 50.64 | 40.46 | Upgrade |
Current Portion of Long-Term Debt | - | - | - | 115.22 | - | - | Upgrade |
Current Portion of Leases | 0.21 | 0.35 | 0.72 | 1.03 | 1.62 | 1.71 | Upgrade |
Other Current Liabilities | 1.08 | 9.54 | 3.31 | 12.39 | 17.55 | 19.51 | Upgrade |
Total Current Liabilities | 22.29 | 22.22 | 19.98 | 197.45 | 81.47 | 73.24 | Upgrade |
Long-Term Debt | - | - | - | - | 83.62 | 81.39 | Upgrade |
Long-Term Leases | - | 0 | 0.46 | 6.44 | 2.57 | 3.81 | Upgrade |
Other Long-Term Liabilities | 0.5 | 0.5 | 0.54 | 3.37 | 4.65 | 7.95 | Upgrade |
Total Liabilities | 22.79 | 22.73 | 20.98 | 207.27 | 172.31 | 166.38 | Upgrade |
Common Stock | 63.4 | 35.04 | 21.44 | 2.84 | 1.5 | 1.05 | Upgrade |
Additional Paid-In Capital | 350.3 | 375.08 | 388.36 | 382.63 | 375.25 | 293.14 | Upgrade |
Retained Earnings | -418.12 | -414.8 | -407.74 | -433.86 | -367.87 | -280.33 | Upgrade |
Shareholders' Equity | -4.41 | -4.68 | 2.07 | -48.4 | 8.88 | 13.86 | Upgrade |
Total Liabilities & Equity | 18.38 | 18.04 | 23.05 | 158.87 | 181.19 | 180.24 | Upgrade |
Total Debt | 0.21 | 0.36 | 1.17 | 122.69 | 87.81 | 86.9 | Upgrade |
Net Cash (Debt) | 2.65 | 4.26 | 4.4 | -102.71 | -49.81 | -57.11 | Upgrade |
Net Cash Growth | -60.53% | -3.07% | - | - | - | - | Upgrade |
Net Cash Per Share | 1.72 | 3.46 | 16.96 | -1666.53 | -1070.52 | -1567.75 | Upgrade |
Filing Date Shares Outstanding | 1.8 | 1.29 | 0.79 | 0.09 | 0.05 | 0.05 | Upgrade |
Total Common Shares Outstanding | 1.8 | 1.29 | 0.79 | 0.09 | 0.05 | 0.04 | Upgrade |
Working Capital | -9.73 | -10.31 | -3.84 | -111.55 | 7.68 | -2.74 | Upgrade |
Book Value Per Share | -2.45 | -3.63 | 2.63 | -519.34 | 168.46 | 361.06 | Upgrade |
Tangible Book Value | -9.94 | -10.23 | -3.51 | -114.03 | -62.77 | -74.02 | Upgrade |
Tangible Book Value Per Share | -5.51 | -7.93 | -4.46 | -1223.51 | -1191.42 | -1927.57 | Upgrade |
Machinery | - | 1.07 | 1.06 | 1.2 | 1.02 | 0.75 | Upgrade |
Leasehold Improvements | - | 0.38 | 0.38 | 0.38 | 0.36 | 0.36 | Upgrade |
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.